Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
MediciNova Inc is a biopharmaceutical company developing novel therapeutics for the treatment of serious diseases with unmet medical needs and a commercial focus on the United States (U.S.) market. It is currently focused on developing MN-166...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of MediciNova (NASDAQ:MNOV) through any online brokerage.
Other companies in MediciNova’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
MediciNova has a consensus price target of $7.20.
The stock price for MediciNova (NASDAQ: MNOV) is $1.62 last updated October 7, 2026 at 4:00 PM EDT.
There are no upcoming dividends for MediciNova.
MediciNova does not have any upcoming earnings scheduled.
There is no upcoming split for MediciNova.
MediciNova is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.